ROLLINS INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data ROLLINS INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	1,573	1,674	1,822	2,015	2,161	2,424	2,696	3,073	3,389	3,761
Cost of revenue	772	820	894	994	1,049	1,163	1,308	1,470	1,603	1,777
Gross profit	801	854	927	1,022	1,113	1,262	1,387	1,603	1,786	1,984
Selling, general and administrative	491	503	551	623	657	727	803	915	1,015	1,133
Operating income				317	376	448	493	583	657	726
Interest expense							2.64	19.1	27.7	28.6
Other non-operating income				-49.3	-8.29	35.7	8.17	22.1	0.68	3.42
Pre-tax income	261	295	311	261	363	482	499	586	630	701
Income tax	93.3	115	79.1	57.8	96	126	130	151	164	174
Net income	167	179	232	203	267	357	369	435	466	527
EBITDA				399	464	534	585	683	770	851
EPS, basic	0.34	0.36	0.47	0.41	0.54	0.72	0.75	0.89	0.96	1.09
EPS, diluted	0.34	0.36	0.47	0.41	0.54	0.72	0.75	0.89	0.96	1.09
Shares, basic (weighted)	495	494	491	491	492	492	492	490	484	484
Shares, diluted (weighted)	495	494	491	491	492	492	492	490	484	484
Dividend per share	0.22	0.24	0.31	0.31	0.33	0.42	0.43	0.54	0.62	0.68

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	143	107	115	94.3	98.5	105	95.3	104	89.6	100
Receivables	88.5	97.8	104	123	126	140	156	178	196	203
Inventory	13.7	15	15.8	19.5	30.8	28.9	29.7	33.4	39.5	43
Other current assets	29.2	25.7	32.3	51	35.4	52.4	34.2	54.2	77.1	82.5
Total current assets	290	263	286	310	315	352	349	407	443	473
Property, plant and equipment	133	134	137	196	178	133	128	127	125	126
Lease right-of-use assets				201	212	245	277	323	414	425
Goodwill	256	347	368	573	718	787	847	1,070	1,161	1,375
Intangible assets	162	162	214			447	419	546	542	582
Other non-current assets	16.8	19.4	19.1		30.6	34.9	39	46.8	45.2	50
Total assets	917	1,034	1,094	1,744	1,846	2,022	2,122	2,595	2,820	3,141
Accounts payable	30.3	26.2	27.2	35.2	64.6	44.6	42.8	49.2	49.6	44.4
Accrued liabilities	75.8	73	77.7	81.9	91	97.9	99.3	114	123	128
Deferred revenue	99.8	109	116	123	131	145	158	172	181	188
Short-term debt									0	124
Total current liabilities	277	295	299	410	473	491	494	577	645	786
Lease liabilities					141	173	197	233	296	291
Total liabilities	348	380	382	929	905	910	855	1,440	1,489	1,766
Total debt				203					395	486
Paid-in capital	77.5	81.4	85.4	89.4	102	106	119	132	155	179
Retained earnings	343	291	370	256	359	530	687	566	735	739
Other comprehensive income	-70.1	-46	-71.1	-21.1	-10.9	-16.4	-31.6	-26.8	-43.6	-25.2
Shareholders' equity	569	654	712	833	965	1,111	1,267	1,156	1,331	1,374
Total equity	569	654	712	833	965	1,111	1,267	1,156	1,331	1,374
Total liabilities and equity	917	1,034	1,094	1,744	1,846	2,022	2,122	2,595	2,820	3,141
Shares outstanding	329	329	327	491	492	492	492	484	484	481

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	167	179	232	203	267	357	369	435	466	527
Depreciation and amortization	50.9	56.6	66.8	81.1	88.3	86.6	91.3	99.8	113	125
Stock-based compensation	12.4	12.4	13.7	14.2	20.9	14.9	21.2	24.6	30	39.7
Deferred income tax	-3.25	18.6	7.63	-7.23	0.85	3.42	1.6	-7.64	-10.3	19.2
Change in receivables	-15.9	-13.7	-12.5	-20.2	-12	-22.4	-34	-45.9	-49.4	-36.4
Change in inventory	-0.67	-0.84	-0.37	-2.15	-10.7	2.64	-0.54	-4.28	-5.87	-1.72
Change in payables	13.3	-25.7	-10.7	5.61	50.1	1.42	0.3	43.4	47.7	-9.49
Cash from operations	227	235	299	320	436	402	466	528	608	678
Capital expenditures	-33.1	-24.7	-27.2	-27.1	-23.2	-27.2	-30.6	-32.5	-27.6	-28.1
Acquisitions	-46.3	-130	-76.8	-431	-148	-146	-119	-367	-157	-310
Cash from investing	-76.8	-154	-101	-455	-162	-99	-134	-373	-176	-327
Debt issued								0	0	492
Debt repaid				-60	-54	-88	-245	-55	0	0
Share buybacks	-31.1	-8.25	-9.54	-10	-8.28	-10.7	-7.07	-315	-11.6	-217
Dividends paid	-109	-122	-153	-154	-160	-209	-212	-264	-298	-328
Cash from financing	-136	-130	-175	112	-281	-290	-336	-149	-441	-344
Exchange rate effect				2.64	12.1	-5.86
Net change in cash	8.21	-35.7	8.44	-21.2	4.2	6.82	-9.96	8.48	-14.2	10.4
Free cash flow	193	211	272	292	413	375	435	496	580	650
Interest paid	0.01	0	0.03	6.45	5.06	1.31	4.16	19.2	32.6	20.2
Income taxes paid	88.8	90.7	77.4	75.8	81.2	120	120	159	146	163

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $30.03 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	52.4%	Gross profit / revenue.
Operating margin	18.7%	Operating income / revenue.
EBITDA margin	22.0%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	17.8%	Pre-tax income / revenue.
Net margin	13.6%	Net income / revenue.
FCF margin	15.8%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	16.5%	Cash from operations / revenue.
Effective tax rate	23.9%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	37.2%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	15.8%	Net income / average total assets.
Return on invested capital (ROIC)	30.8%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	30.4%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.1%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	0.7%	Capital expenditures / revenue.
D&A / revenue	3.3%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	11.0%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	11.7%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	11.7%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	11.1%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	12.7%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	12.3%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	10.5%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	13.7%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	14.1%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	10.4%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	13.3%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	12.9%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	12.9%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	12.6%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	14.6%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	13.5%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	13.3%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	15.1%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	11.6%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	13.3%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	9.2%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	12.1%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	14.3%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	9.5%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	10.2%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	16.4%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	15.5%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	3.3%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	2.7%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	7.3%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	11.4%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	14.0%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	11.2%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-0.0%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-0.6%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-0.3%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	0.63x	Current assets / current liabilities.
Quick ratio	0.37x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.12x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.34x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	14.5%	Total debt / total assets.
Liabilities / assets	57.4%	Total liabilities / total assets.
Net debt	$378.0M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	0.44x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	21.8x	Operating income / interest expense.
Working capital	-$347.7M	Current assets - current liabilities.
Goodwill and intangibles / assets	61.1%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$621.3M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.17x	Revenue / average total assets.
Fixed asset turnover	31.0x	Revenue / average property, plant and equipment.
Inventory turnover	43.7x	Cost of revenue / average inventory.
Days inventory	8 days	365 x average inventory / cost of revenue.
Receivables turnover	16.4x	Revenue / average receivables.
Days sales outstanding	22 days	365 x average receivables / revenue.
Days payables	16 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	15 days	Days inventory + days sales outstanding - days payables.
FCF conversion	116.4%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	4.3%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$1.10	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$8.15	Revenue / diluted weighted shares.
FCF per share	$1.29	Free cash flow / diluted weighted shares.
Operating cash flow per share	$1.34	Cash from operations / diluted weighted shares.
Book value per share	$2.97	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$1.29	Tangible book value / shares outstanding.
Cash per share	$0.23	(Cash + short-term investments) / shares outstanding.
Payout ratio	64.8%	Dividends paid / net income, when net income is positive.
Dividends / FCF	55.6%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	39.5%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$14.45B	Share price x shares outstanding.
Enterprise value	$14.83B	Market cap + total debt - cash - short-term investments.
P/E	27.2x	Market cap / net income. Only when net income is positive.
P/S	3.68x	Market cap / revenue.
P/B	10.1x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	23.3x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	22.3x	Market cap / cash from operations, when positive.
EV/Sales	3.78x	Enterprise value / revenue.
EV/EBIT	20.3x	Enterprise value / operating income, when both are positive.
EV/EBITDA	17.2x	Enterprise value / EBITDA, when both are positive.
EV/FCF	23.9x	Enterprise value / free cash flow, when both are positive.
FCF yield	4.3%	Free cash flow / market cap.
Earnings yield	3.7%	Net income / market cap (the inverse of P/E).
Dividend yield	2.4%	Dividends paid over the period / market cap.
Shareholder yield	4.1%	(Dividends paid + share buybacks) / market cap.
PEG	2.05x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was ROLLINS INC's revenue in fiscal 2025?

ROLLINS INC reported revenue of $3.76B for fiscal 2025, 11% higher than the year before.

Was ROLLINS INC profitable in fiscal 2025?

Yes. Net income was $526.7M, a net margin of 14%.

How much free cash flow did ROLLINS INC generate in fiscal 2025?

Cash from operations of $678.1M minus capital expenditures of $28.1M left free cash flow of $650.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to ROLLINS INC